PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer.

Terracciano D, Pellegrino F, Fiorenza M, Polito C, Sirica R, Fallara G, Bianchi R, Chierigo F, Maggi M, Tozzi M, Jannello LMI, Santangelo E, Martorello V, Triggiani A, Crocetto F, Imbimbo C, Del Giudice F, Barone B, Cincione A, Autorino R, De Nunzio C, Ferro M

Open source

DOI
10.1038/s41391-026-01158-9
Published
2026 Sep 23
Container
Prostate cancer and prostatic diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41391-026-01158-9,
  title = {PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer.},
  author = {Terracciano D and Pellegrino F and Fiorenza M and Polito C and Sirica R and Fallara G and Bianchi R and Chierigo F and Maggi M and Tozzi M and Jannello LMI and Santangelo E and Martorello V and Triggiani A and Crocetto F and Imbimbo C and Del Giudice F and Barone B and Cincione A and Autorino R and De Nunzio C and Ferro M},
  year = {2026},
  journal = {Prostate cancer and prostatic diseases},
  doi = {10.1038/s41391-026-01158-9},
  url = {https://doi.org/10.1038/s41391-026-01158-9}
}

RIS

TY  - JOUR
TI  - PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer.
AU  - Terracciano D
AU  - Pellegrino F
AU  - Fiorenza M
AU  - Polito C
AU  - Sirica R
AU  - Fallara G
AU  - Bianchi R
AU  - Chierigo F
AU  - Maggi M
AU  - Tozzi M
AU  - Jannello LMI
AU  - Santangelo E
AU  - Martorello V
AU  - Triggiani A
AU  - Crocetto F
AU  - Imbimbo C
AU  - Del Giudice F
AU  - Barone B
AU  - Cincione A
AU  - Autorino R
AU  - De Nunzio C
AU  - Ferro M
PY  - 2026
JO  - Prostate cancer and prostatic diseases
DO  - 10.1038/s41391-026-01158-9
UR  - https://doi.org/10.1038/s41391-026-01158-9
ER  - 

APA

D, T., F, P., M, F., C, P., R, S., G, F., R, B., F, C., M, M., M, T., LMI, J., E, S., V, M., A, T., F, C., C, I., F, D. G., B, B., A, C., R, A., C, D. N., & M, F. (2026). PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer.. Prostate cancer and prostatic diseases. https://doi.org/10.1038/s41391-026-01158-9

Source records